2026 BD opportunity scan for Hisamitsu Pharmaceutical Co., Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rat

2026 BD opportunity scan for HighField Biopharmaceuticals, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rat

2026 BD opportunity scan for Help Therapeutics Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for HeiLongJiang ZBD Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Heilongjiang Kuihua Pharmaceutical Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and out

2026 BD opportunity scan for Harmony Biosciences Management, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r

2026 BD opportunity scan for Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals a

2026 BD opportunity scan for Hangzhou Yirui Pharmaceutical Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals

2026 BD opportunity scan for Hangzhou Shangjian Biotechnology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outr

2026 BD opportunity scan for Hangzhou QIANYUAN Pollen Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals a

2026 BD opportunity scan for Hangzhou Highlightll Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and o

2026 BD opportunity scan for Hangzhou Chengbang Pharmaceutical Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial sign